DOCSLIB.ORG

ICD-10-CM Codes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ICD-10-CM Codes ICD-10 common codes for Gynecology and Obstetrics Code Diagnoses Code Diagnoses Menstrual abnormalities Z11.8 Trichomoniasis screening Contact with and (suspected) exposure to infections N91.2 Amenorrhea Z20.2 with a predominantly sexual mode of transmission N91.5 Oligomenorrhea Z72.51 High risk heterosexual behavior N92.0 Menorrhagia Z72.52 High risk homosexual behavior N92.1 Metrorrhagia Z73.53 High risk bisexual behavior N92.6 Irregular menses Z72.89 Other problems related to lifestyle N93.8 Dysfunctional uterine bleeding Disorders of cervix N94.3 Premenstrual syndrome D06.9 Cervical Intraepithelial Neoplasia III (CIN III) N94.6 Dysmenorrhea N72 Cervical Inflammation Disorders of genital area N72 Cervicitis/Endocervicitis L29.3 Vaginal itch N84.1 Cervical Polyp N73.9 Pelvic inflammatory disease (PID) N87.1 Mild Dysplasia Of Cervix (CIN I) N75.0 Bartholin’s cyst N87.2 Moderate Dysplasia Of Cervix (CIN II) N76.0 Vaginitis, unspecified N76.4 Vulvar abscess Menopause N76.5 Vaginal ulcer N95.0 Postmenopausal bleeding N76.6 Ulcer of vulva N95.1 Menopausal symptoms N89.4 Leukoplakia of vagina N95.2 Senile atrophic vaginitis N89.8 Vaginal cyst N95.8 Perimenopausal bleeding N89.8 Vaginal discharge N95.8 Postsurgical menopause N89.9 Noninflammatory disorder of vagina Abnormal Pap Smear results N90.89 Vulvar lesion R87.610 ASC-US, Cervix N93.9 Vaginal bleeding R87.611 ASC-H, Cervix N94.9 Pelvic pain R87.612 LGSIL, Cervix R19.00 Pelvic mass R87.613 HGSIL, Cervix Screening for Infectious Diseases R87.615 Unsatisfactory Cervical Cytology sample Z11.3 Syphilis screening R87.619 Abnormal Pap Smear Result, Cervix Z11.3 Venereal disease screening R87.628 Abnormal Pap Smear Result, Vagina Z11.51 HPV screening R87.810 Cervical High-Risk HPV Test Positive Z11.59 Hepatitis screening R87.811 Vaginal High-Risk HPV Test Positive Z11.59 HIV screening Disorders of uterus and ovary Z11.59 Rubella screening D25.9 Uterine fibroid/leiomyoma Z11.8 Chlamydial trachomatis screening E28.39 Ovarian failure Z11.8 Screening for yeast infection E28.9 Ovarian dysfunction ICD-10 common codes for Gynecology and Obstetrics Code Diagnoses Code Diagnoses N80.0 Adenomyosis B37.3 Candidiasis, vulva and vagina N80.0 Cervical endometriosis B96.89 Gram-negative anaerobic infection N80.9 Endometriosis, unspecified Neoplasm of female genital organs N83.20 Ovarian cyst C50.919 Breast cancer N84.0 Uterine polyp C51.9 Vulvar cancer N85.2 Enlarged uterus C52 Vaginal cancer N85.8 Uterine cyst C53.0 Endocervical cancer N94.89 Ovarian mass C53.9 Cervical cancer Routine examination codes C54.1 Endometrial cancer Z01.419 Routine gynecological examination C55 Uterine cancer Z12.4 Routine cervical papanicolau smear C56.9 Ovarian cancer Z12.72 Vaginal pap smear status post-hysterectomy Pregnancy: supervision of pregnancy and postpartum Z77.9 High-risk for developing cervical cancer O09.511 Advanced maternal age, first trimester Disorders of breast O09.512 Advanced maternal age, second trimester N60.09 Cyst of breast O09.513 Advanced maternal age, third trimester N60.19 Fibrocystic breast O09.519 Advanced maternal age, unspecified trimester N61.1 Breast abscess Advanced maternal age, other than first pregnancy, O09.521 N61.1 Mastitis (breast abscess) first trimester Advanced maternal age, other than first pregnancy, N64.3 Galactorrhea not associated with childbirth O09.522 second trimester N64.4 Mastodynia (pain in breast) Advanced maternal age, other than first pregnancy, O09.523 N64.52 Nipple discharge third trimester Advanced maternal age, other than first pregnancy, N64.59 Breast tenderness O09.529 unspecified trimester Genital Tract Infections Pregnancy resulting from in vitro fertilization, O09.811 A51.0 Genital syphilis first trimester A59.00 Trichomoniasis, urogenital Pregnancy resulting from in vitro fertilization, O09.812 second trimester A59.01 Trichomoniasis, vulvovaginitis Pregnancy resulting from in vitro fertilization, O09.813 A60.04 Herpetic ulceration of vulva third trimester A60.04 Herpetic vulvovaginitis Pregnancy resulting from in vitro fertilization, O09.819 unspecified trimester A60.9 Genital herpes O09.891 High-risk pregnancy, first trimester A74.89 Chlamydia trachomatis O09.892 High-risk pregnancy, second trimester A74.9 Chlamydial infection ICD-10 common codes for Gynecology and Obstetrics Code Diagnoses Code Diagnoses O09.893 High-risk pregnancy, third trimester Genetic carrier status O09.899 High-risk pregnancy, unspecified trimester Z14.1 Cystic fibrosis gene carrier Z13.9 Screening Z14.8 Genetic carrier status, other than cystic fibrosis Z34.00 Normal first pregnancy, unspecified trimester Z84.81 Family history of genetic disease carrier Z34.01 Normal first pregnancy, first trimester Complications of pregnancy Z34.02 Normal first pregnancy, second trimester Gestational hypertension, without O13.1 significant proteinuria, first trimester Z34.03 Normal first pregnancy, third trimester Gestational hypertension, without Normal pregnancy other than first, unspecified, O13.2 Z34.90 significant proteinuria, second trimester unspecified trimester Gestational hypertension, without Normal pregnancy other than first, unspecified, O13.3 Z34.91 significant proteinuria, third trimester first trimester Gestational hypertension, without Normal pregnancy other than first, unspecified, O13.9 Z34.92 significant proteinuria, unspecified trimester second trimester O14.00 Mild pre-eclampsia, unspecified trimester Normal pregnancy other than first, unspecified, Z34.93 third trimester O14.02 Mild pre-eclampsia, second trimester Z36 Antenatal screening for chromosal anomaly O14.03 Mild pre-eclampsia, third trimester Antenatal screening for alpha-fetoprotein in Mild to moderate pre-eclampsia, Z36 O14.04 amniotic fluid complicating childbirth Z36 First trimester screen Mild to moderate pre-eclampsia, O14.05 complicating puerperium Z36 Routine fetal ultrasound O24.419 Gestational diabetes, unspecified control Z39.2 Routine postpartum follow-up Habitual aborter with current pregnancy, O26.20 Genetic testing unspecified trimester Nonprocreative screening for genetic disease Habitual aborter with current pregnancy, Z13.71 O26.21 carrier status first trimester Z31.430 Genetic screening for cystic fibrosis, female Habitual aborter with current pregnancy, O26.22 second trimester Testing of female for genetic disease carrier status, Z31.430 procreative Habitual aborter with current pregnancy, O26.23 third trimester Z31.438 Genetic procreative testing of female O26.851 Spotting complicating pregnancy, first trimester Testing of male for genetic disease carrier status, Z31.440 procreative O26.852 Spotting complicating pregnancy, second trimester Testing of partner of female with recurrent O26.853 Spotting complicating pregnancy, third trimester Z31.441 pregnancy loss Spotting complicating pregnancy, O26.859 Z31.49 Procreative management testing unspecified trimester Z31.5 Genetic counseling O30.001 Twin pregnancy, first trimester ICD-10 common codes for Gynecology and Obstetrics Code Diagnoses Code Diagnoses Placenta previa without hemorrhage, O30.002 Twin pregnancy, second trimester O44.03 third trimester O30.003 Twin pregnancy, third trimester Hemorrhage from placenta previa, O44.10 O30.009 Twin pregnancy, unspecified trimester unspecified trimester Rh incompatibility affecting management O44.11 Hemorrhage from placenta previa, first trimester O36.0110 of pregnancy, first trimester O44.12 Hemorrhage from placenta previa, second trimester Rh incompatibility affecting management O36.0120 O44.13 Hemorrhage from placenta previa, third trimester of pregnancy, second trimester Post-term pregnancy Rh incompatibility affecting management O48.0 O36.0130 (between 40 & 42 weeks gestation) of pregnancy, third trimester O99.345 Postpartum depression Rh incompatibility affecting management O36.0190 of pregnancy, unspecified trimester Pregnancy with abortive outcomes O36.5910 Poor fetal growth, first trimester O00.10 Tubal pregnancy without intrauterine pregnancy O36.5920 Poor fetal growth, second trimester O00.11 Tubal pregnancy with intrauterine pregnancy Unspecified ectopic pregnancy without O36.5930 Poor fetal growth, third trimester O00.90 intrauterine pregnancy O36.5990 Poor fetal growth, unspecified trimester Unspecified ectopic pregnancy with O00.91 O36.60X0 Excessive fetal growth, unspecified trimester intrauterine pregnancy O36.61X0 Excessive fetal growth, first trimester O01.9 Hydatidiform mole O36.62X0 Excessive fetal growth, second trimester O02.0 Blighted ovum O36.63X0 Excessive fetal growth, third trimester O02.0 Molar pregnancy Placenta previa without hemorrhage, O02.1 Missed abortion O44.00 unspecified trimester O03.9 Spontaneous abortion (miscarriage) Placenta previa without hemorrhage, O44.01 O20.0 Threatened abortion first trimester O36.4XX0 Intrauterine death, unspecified Placenta previa without hemorrhage, O44.02 second trimester Z33.2 Abortion * The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed. This list is intended to assist ordering physicians in providing ICD-10 Diagnostics codes as required by Medicare and other Insurers. It includes some commonly found ICD-10 codes. This list was compiled from the ICD-10-CM 2017 AMA manual. A current ICD-10-CM book should be used as a complete reference. The ultimate responsibility for correct coding belongs to the ordering physician. QuestDiagnostics.com Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks–® and ™– are the property of their respective owners. © 2017 Quest Diagnostics Incorporated. All rights reserved. MI3858 7/2017.
Load more

Recommended publications
  • Spectrum of Benign Breast Diseases in Females- a 10 Years Study
    Original Article Spectrum of Benign Breast Diseases in Females- a 10 years study Ahmed S1, Awal A2 Abstract their life time would have had the sign or symptom of benign breast disease2. Both the physical and specially the The study was conducted to determine the frequency of psychological sufferings of those females should not be various benign breast diseases in female patients, to underestimated and must be taken care of. In fact some analyze the percentage of incidence of benign breast benign breast lesions can be a predisposing risk factor for diseases, the age distribution and their different mode of developing malignancy in later part of life2,3. So it is presentation. This is a prospective cohort study of all female patients visiting a female surgeon with benign essential to recognize and study these lesions in detail to breast problems. The study was conducted at Chittagong identify the high risk group of patients and providing regular Metropolitn Hospital and CSCR hospital in Chittagong surveillance can lead to early detection and management. As over a period of 10 years starting from July 2007 to June the study includes a great number of patients, this may 2017. All female patients visiting with breast problems reflect the spectrum of breast diseases among females in were included in the study. Patients with obvious clinical Bangladesh. features of malignancy or those who on work up were Aims and Objectives diagnosed as carcinoma were excluded from the study. The findings were tabulated in excel sheet and analyzed The objective of the study was to determine the frequency of for the frequency of each lesion, their distribution in various breast diseases in female patients and to analyze the various age group.
    [Show full text]
  • Breastfeeding and Women's Mental Health
    BREASTFEEDING AND WOMEN’S MENTAL HEALTH Julie Demetree, MD University of Arizona Department of Psychiatry Disclosures ◦ Nothing to disclose, currently paid by Banner University Medical Center, and on faculty at University of Arizona. Goals and Objectives ◦ Review the basic physiology involved in breastfeeding ◦ Learn about literature available regarding mood, sleep and breastfeeding ◦ Know the resources available to refer to regarding pharmacology and breast feeding ◦ Understand principles of psychopharmacology involved in breastfeeding, including learning about some specific medications, to be able to counsel a woman and obtain informed consent ◦ Be aware of syndrome described as Dysphoric Milk Ejection Reflex Lactation Physiology https://courses.lumenlearning.com/boundless-ap/chapter/lactation/ AAP Material on Breastfeeding AAP: Breastfeeding Your Baby 2015 AAP Material on Breastfeeding AAP: Breastfeeding Your Baby 2015 A Few Numbers ◦ About 80% of US women breastfeed ◦ 10-15% of women suffer from post partum depression or anxiety ◦ 1-2/1000 suffer from post partum psychosis Depression and Infant Care ◦ Depressed mothers are: ◦ More likely to misread infant cues 64 ◦ Less likely to read to infant ◦ Less likely to follow proper safety measures ◦ Less likely to follow preventative care advice 65 Depression is Associated with Decreased Chance of Breastfeeding ◦ A review of 75 articles found “women with depressive symptomatology in the early postpartum period may be at increased risk for negative infant-feeding outcomes including decreased breastfeeding duration, increased breastfeeding difficulties, and decreased levels of breastfeeding self-efficacy.” 1 Depressive Symptoms and Risk of Formula Feeding ◦ An Italian study with 592 mothers participating by completing the Edinburgh Postnatal Depression Scale immediately after delivery and then feeding was assessed at 12-14 weeks where asked if breast, formula or combo feeding.
    [Show full text]
  • Unilateral Galactorrhea Associated with Low-Dose Escitalopram
    Case Report Unilateral Galactorrhea Associated with Low-dose Escitalopram P. Bangalore Ravi, K. G. Guruprasad1, Chittaranjan Andrade2 ABSTRACT Galactorrhea is a rare adverse effect of selective serotonin reuptake inhibitor treatment. We report a 27-year-old woman who developed unilateral breast engorgement with galactorrhea 18 days after initiation of escitalopram (10 mg/day). The symptom remitted 7 days after withdrawal of escitalopram and did not subsequently recur during maintenance therapy with agomelatine (25 mg/day). Key words: Agomelatine, escitalopram, galactorrhea, prolactin, selective serotonin reuptake inhibitor, unilateral breast engorgement INTRODUCTION about the future, low self-confidence, diminished interest in daily activities, and diminished interest in social life, Galactorrhea refers to the discharge of milk from the poor appetite, and poor sleep. These symptoms were breast, unassociated with recent childbirth or nursing. exacerbated by domestic stress and absence of social Galactorrhea occurs when serum prolactin levels are support. A diagnosis of moderate depression with raised for reasons ranging from pituitary tumors to drug somatic symptoms was made, and she was started on treatments. A number of drugs, including psychotropic escitalopram 5 mg/day along with clonazepam 0.75 mg/day. She was instructed to increase the dose of drugs, cause hyperprolactinemia, some doing so consistently escitalopram to 10 mg/day after 4 days and taper and (e.g., certain antipsychotics), and some, rarely (e.g., certain withdraw the clonazepam at the rate of 0.25 mg/week. antidepressants).[1,2] We herein report an unusual case of galactorrhea resulting from escitalopram use. After about 18 days of treatment, she developed painless engorgement of her left breast associated with CASE REPORT galactorrhea.
    [Show full text]
  • Breast Concerns
    Section 12.0: Preventive Health Services for Women Clinical Protocol Manual 12.2 BREAST CONCERNS TITLE DESCRIPTION DEFINITION: Breast concerns in women of all ages are often the source of significant fear and anxiety. These concerns can take the form of palpable masses or changes in breast contours, skin or nipple changes, congenital malformation, nipple discharge, or breast pain (cyclical and non-cyclical). 1. Palpable breast masses may represent cysts, fibroadenomas or cancer. a. Cysts are fluid-filled masses that can be found in women of all ages, and frequently develop due to hormonal fluctuation. They often change in relation to the menstrual cycle. b. Fibroadenomas are benign sold tumors that are caused by abnormal growth of the fibrous and ductal tissue of the breast. More common in adolescence or early twenties but can occur at any age. A fibroadenoma may grow progressively, remain the same, or regress. c. Masses that are due to cancer are generally distinct solid masses. They may also be merely thickened areas of the breast or exaggerated lumpiness or nodularity. It is impossible to diagnose the etiology of a breast mass based on physical exam alone. Failure to diagnose breast cancer in a timely manner is the most common reason for malpractice litigation in the U.S. Skin or nipple changes may be visible signs of an underlying breast cancer. These are danger signs and require MD referral. 2. Non-spontaneous or physiological discharge is fluid that may be expressed from the breast and is not unusual in healthy women. 3. Galactorrhea is a spontaneous, multiple duct, milky discharge most commonly found in non-lactating women during childbearing years.
    [Show full text]
  • Management of Prolonged Decelerations ▲
    OBG_1106_Dildy.finalREV 10/24/06 10:05 AM Page 30 OBGMANAGEMENT Gary A. Dildy III, MD OBSTETRIC EMERGENCIES Clinical Professor, Department of Obstetrics and Gynecology, Management of Louisiana State University Health Sciences Center New Orleans prolonged decelerations Director of Site Analysis HCA Perinatal Quality Assurance Some are benign, some are pathologic but reversible, Nashville, Tenn and others are the most feared complications in obstetrics Staff Perinatologist Maternal-Fetal Medicine St. Mark’s Hospital prolonged deceleration may signal ed prolonged decelerations is based on bed- Salt Lake City, Utah danger—or reflect a perfectly nor- side clinical judgment, which inevitably will A mal fetal response to maternal sometimes be imperfect given the unpre- pelvic examination.® BecauseDowden of the Healthwide dictability Media of these decelerations.” range of possibilities, this fetal heart rate pattern justifies close attention. For exam- “Fetal bradycardia” and “prolonged ple,Copyright repetitive Forprolonged personal decelerations use may onlydeceleration” are distinct entities indicate cord compression from oligohy- In general parlance, we often use the terms dramnios. Even more troubling, a pro- “fetal bradycardia” and “prolonged decel- longed deceleration may occur for the first eration” loosely. In practice, we must dif- IN THIS ARTICLE time during the evolution of a profound ferentiate these entities because underlying catastrophe, such as amniotic fluid pathophysiologic mechanisms and clinical 3 FHR patterns: embolism or uterine rupture during vagi- management may differ substantially. What would nal birth after cesarean delivery (VBAC). The problem: Since the introduction In some circumstances, a prolonged decel- of electronic fetal monitoring (EFM) in you do? eration may be the terminus of a progres- the 1960s, numerous descriptions of FHR ❙ Complete heart sion of nonreassuring fetal heart rate patterns have been published, each slight- block (FHR) changes, and becomes the immedi- ly different from the others.
    [Show full text]
  • Induction Indication: Advanced Maternal Age
    INDUCTION INDICATION: ADVANCED MATERNAL AGE DOCUMENT TYPE: REFERENCE TOOL Level of Evidence INDUCTION INDICATION: Maternal Age ≥ 40 years RECOMMENDATION: Offer Induction at ≥ 39 weeks gestation Recommendation for labour induction: II-B Recommendation for timing of labour induction: II-B Recommendations for priority: II-B Definition The average age of childbirth is rising in developed countries. The definition of advanced maternal age for the purposes of this document is greater than or equal to 40 years of age. Studies report that advanced maternal age is associated with increased pregnancy risk for both mother and baby. Although the incidence of stillbirth at term is low, it is higher in women of advanced maternal age.1 Outcomes There are known adverse perinatal outcomes for women who are of advanced maternal age. When compared to younger women, in older women there is increased risk for placental abruption, placenta previa, malpresentation, growth restriction, preterm and postdates delivery as well as postpartum hemorrhage. Even after controlling for medical co-morbidities, advanced maternal age is found to be associated with an increase in antenatal and intrapartum stillbirth.2 The relative risk of stillbirth for women ≥ 40 years of age, for both multiparous and primiparous women is 1.2 to 4.5. The cumulative risk of stillbirth in women 40 and older at 39 weeks gestation is similar to mothers 25 to 29 years at 41 weeks gestation3,4. The mechanism for increased risk of stillbirth in older mothers is as yet unknown. Recommendations Labour induction may be offered to mothers who are greater than or equal to 40 years of age at 39 weeks of gestation.
    [Show full text]
  • Evaluation of Nipple Discharge
    New 2016 American College of Radiology ACR Appropriateness Criteria® Evaluation of Nipple Discharge Variant 1: Physiologic nipple discharge. Female of any age. Initial imaging examination. Radiologic Procedure Rating Comments RRL* Mammography diagnostic 1 See references [2,4-7]. ☢☢ Digital breast tomosynthesis diagnostic 1 See references [2,4-7]. ☢☢ US breast 1 See references [2,4-7]. O MRI breast without and with IV contrast 1 See references [2,4-7]. O MRI breast without IV contrast 1 See references [2,4-7]. O FDG-PEM 1 See references [2,4-7]. ☢☢☢☢ Sestamibi MBI 1 See references [2,4-7]. ☢☢☢ Ductography 1 See references [2,4-7]. ☢☢ Image-guided core biopsy breast 1 See references [2,4-7]. Varies Image-guided fine needle aspiration breast 1 Varies *Relative Rating Scale: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate Radiation Level Variant 2: Pathologic nipple discharge. Male or female 40 years of age or older. Initial imaging examination. Radiologic Procedure Rating Comments RRL* See references [3,6,8,10,13,14,16,25- Mammography diagnostic 9 29,32,34,42-44,71-73]. ☢☢ See references [3,6,8,10,13,14,16,25- Digital breast tomosynthesis diagnostic 9 29,32,34,42-44,71-73]. ☢☢ US is usually complementary to mammography. It can be an alternative to mammography if the patient had a recent US breast 9 mammogram or is pregnant. See O references [3,5,10,12,13,16,25,30,31,45- 49]. MRI breast without and with IV contrast 1 See references [3,8,23,24,35,46,51-55].
    [Show full text]
  • Oocyte Or Embryo Donation to Women of Advanced Reproductive Age: an Ethics Committee Opinion
    ASRM PAGES Oocyte or embryo donation to women of advanced reproductive age: an Ethics Committee opinion Ethics Committee of the American Society for Reproductive Medicine American Society for Reproductive Medicine, Birmingham, Alabama Advanced reproductive age (ARA) is a risk factor for female infertility, pregnancy loss, fetal anomalies, stillbirth, and obstetric com- plications. Oocyte donation reverses the age-related decline in implantation and birth rates of women in their 40s and 50s and restores pregnancy potential beyond menopause. However, obstetrical complications in older patients remain high, particularly related to oper- ative delivery and hypertensive and cardiovascular risks. Physicians should perform a thorough medical evaluation designed to assess the physical fitness of a patient for pregnancy before deciding to attempt transfer of embryos to any woman of advanced reproductive age (>45 years). Embryo transfer should be strongly discouraged or denied to women of ARA with underlying conditions that increase or exacerbate obstetrical risks. Because of concerns related to the high-risk nature of pregnancy, as well as longevity, treatment of women over the age of 55 should generally be discouraged. This statement replaces the earlier ASRM Ethics Committee document of the same name, last published in 2013 (Fertil Steril 2013;100:337–40). (Fertil SterilÒ 2016;106:e3–7. Ó2016 by American Society for Reproductive Medicine.) Key Words: Ethics, third-party reproduction, complications, pregnancy, parenting Discuss: You can discuss
    [Show full text]
  • Burns, Hypertrophic Scar and Galactorrhea
    Karimi H et al. Injury & Violence 117 J Inj Violence Res. 2013 Jun; 5(2): 117-119. doi: 10.5249/ jivr.v5i2.314 Case Report Burns, hypertrophic scar and galactorrhea Hamid Karimi a , Samad Nourizad a ,* , Mahnoush Momeni a, Hosein Rahbar a, Mazdak Momeni b, Khosro Farhadi c a Faculty of Medicine, Tehran University of Medical Sciences,Tehran, Iran. b Baylor College of Medicine, Houston, Texas, USA. c Department of Anesthesiology, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran. Abstract: An 18-year old woman was admitted to Motahari Burn Center suffering from 30% burns. KEY WORDS Treatment modalities were carried out for the patient and she was discharged after 20 days. Three to four months later she developed hypertrophic scar on her chest and upper limbs. At the same time she developed galactorrhea in both breasts and had a disturbed menstrual cycle four Burns months post-burn. On investigation, we found hyperprolactinemia and no other reasons for the Hypertrophic scar high level of prolactin were detected. Galactorrhea She received treatment for both the hypertrophic scar and the severe itching she was experiencing. After seven months, her prolactin level had decreased but had not returned to the normal level. It seems that refractory hypertrophic scar is related to the high level of prolactin in burns patients. Received 2012-09-28 Accepted 2013-01-23 © 2013 KUMS, All rights reserved *Corresponding Author at: Dr. Samad Nourizad: Department of Anesthesiology, Tehran University of Medical Science, Tehran, Iran, Email: [email protected] (Nourizad S.). © 2013 KUMS, All rights reserved Introduction sis, i.e.
    [Show full text]
  • Pregnancy After Age 35
    REFLECTING ON THE TREND: Pregnancy After Age 35 A guide to Advanced Maternal Age for Ontario service providers, including a summary of statistical trends, influencing factors, health benefits, health risks and recommendations for care. A collaborative project of: Best Start: Ontario’s Maternal, Newborn and Early Child Development Resource Centre and the Halton Region Health Department 2007 ACKNOWLEDGEMENTS This Best Start Resource Centre manual was developed in collaboration with the Halton Region Health Department. The Best Start Resource Centre would like to thank Halton Region’s Health Department for entering into this partnership, and Kathryn Bamford, Reproductive Health Manager, for her persistence in determining a strategy to make this happen. The Halton Region Health Department is located west of Toronto and is responsible for public health in the communities of Burlington, Halton Hills, Milton and Oakville. Halton region has one of the highest rates of pregnancy over the age of 35 in Ontario, and is very interested in strategies for care of this population. For more information on the Halton Region Health Department, call 905-825-6000 or visit www.halton.ca/health The Best Start Resource Centre would like to thank Michelle Schwarz, BScN, MPA, Public Health Nurse, at the Halton Region Health Department for her work in researching and drafting this publication. Best Start would also like to Key Informants and • Joyce Engel, PhD, • Hana Sroka, MSc, CCGC, acknowledge the important Expert Reviewers: Vice-President, Academic Genetic Counsellor, Mount Niagara College Sinai Hospital roles played by the following • Dr. Sean Blaine, BSc, MD Halton Region staff: CCFP, Lead Physician, STAR • Dr.
    [Show full text]
  • OBGYN-Study-Guide-1.Pdf
    OBSTETRICS PREGNANCY Physiology of Pregnancy: • CO input increases 30-50% (max 20-24 weeks) (mostly due to increase in stroke volume) • SVR anD arterial bp Decreases (likely due to increase in progesterone) o decrease in systolic blood pressure of 5 to 10 mm Hg and in diastolic blood pressure of 10 to 15 mm Hg that nadirs at week 24. • Increase tiDal volume 30-40% and total lung capacity decrease by 5% due to diaphragm • IncreaseD reD blooD cell mass • GI: nausea – due to elevations in estrogen, progesterone, hCG (resolve by 14-16 weeks) • Stomach – prolonged gastric emptying times and decreased GE sphincter tone à reflux • Kidneys increase in size anD ureters dilate during pregnancy à increaseD pyelonephritis • GFR increases by 50% in early pregnancy anD is maintaineD, RAAS increases = increase alDosterone, but no increaseD soDium bc GFR is also increaseD • RBC volume increases by 20-30%, plasma volume increases by 50% à decreased crit (dilutional anemia) • Labor can cause WBC to rise over 20 million • Pregnancy = hypercoagulable state (increase in fibrinogen anD factors VII-X); clotting and bleeding times do not change • Pregnancy = hyperestrogenic state • hCG double 48 hours during early pregnancy and reach peak at 10-12 weeks, decline to reach stead stage after week 15 • placenta produces hCG which maintains corpus luteum in early pregnancy • corpus luteum produces progesterone which maintains enDometrium • increaseD prolactin during pregnancy • elevation in T3 and T4, slight Decrease in TSH early on, but overall euthyroiD state • linea nigra, perineum, anD face skin (melasma) changes • increase carpal tunnel (median nerve compression) • increased caloric need 300cal/day during pregnancy and 500 during breastfeeding • shoulD gain 20-30 lb • increaseD caloric requirements: protein, iron, folate, calcium, other vitamins anD minerals Testing: In a patient with irregular menstrual cycles or unknown date of last menstruation, the last Date of intercourse shoulD be useD as the marker for repeating a urine pregnancy test.
    [Show full text]
  • Induction of Labour at Term in Older Mothers
    Induction of Labour at Term in Older Mothers Scientific Impact Paper No. 34 February 2013 Induction of Labour at Term in Older Mothers 1. Background and introduction The average age of childbirth is rising markedly across Western countries.1 In the United Kingdom (UK) the proportion of maternities in women aged 35 years or over has increased from 8% (approximately 180 000 maternities) in 1985–87 to 20% (almost 460 000 maternities) in 2006–8 and in women aged 40 years and older has trebled in this time from 1.2% (almost 27 000 maternities) to 3.6% (approximately 82 000 maternities).2 There is a continuum of risk for both mother and baby with rising maternal age with numerous studies reporting multiple adverse fetal and maternal outcomes associated with advanced maternal age. Obstetric complications including placental abruption,3 placenta praevia, malpresentation, low birthweight,4–7 preterm8 and post–term delivery9 and postpartum haemorrhage,10 are higher in older mothers. As fertility declines with age, there is a greater use of assisted reproductive technologies (ARTs) and the possibility of multiple pregnancy increases. This may independently adversely affect the risks reported.11 Preexisting maternal medical conditions including hypertension, obesity and diabetes increase with advancing maternal age as do pregnancy–related maternal complications such as pre–eclampsia and gestational diabetes.12 These medical co–morbidities can all influence fetal health and are likely to compound the effect of age on the risk of pregnancy in an older
    [Show full text]